GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Stevanato Group SpA STVN · USD

Health Care · US listing · 🇺🇸 United States

Compare

13.73

+1.18%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€1.32bn

FY2019FY2025

Net income

€155.0m

FY2019FY2025

Free cash flow

€24.7m

FY2019FY2025

Shareholders' equity

€1.71bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue€1.32bn€1.27bn€1.25bn€1.14bn€974.0m€764.1m€619.2m
Gross profit€381.2m€348.9m€392.3m€369.1m€306.3m€224.1m€159.3m
Research and development€28.2m€36.5m€41.2m€39.7m€34.2m€20.1m€9.0m
Operating income€211.3m€186.0m€231.7m€222.1m€192.4m€118.0m€71.8m
Net income€155.0m€135.9m€168.1m€164.9m€155.0m€90.6m€45.2m
Diluted earnings per share0.570.500.630.620.590.310.17

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets€2.93bn€2.69bn€2.39bn€1.92bn€1.64bn€1.12bn€1.02bn
Cash and short-term investments€153.2m€113.4m€81.2m€296.2m€505.7m€181.3m€145.7m
Total liabilities€1.22bn€1.07bn€1.08bn€766.1m€666.1m€759.2m€711.8m
Debt€468.9m€429.0m€396.6m€667.1m€243.3m€362.0m€374.7m
Shareholders' equity€1.71bn€1.62bn€1.31bn€1.15bn€971.8m€358.3m€306.4m
Shares outstanding273m273m266m265m265m295m265m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations€317.1m€179.8m€121.4m€119.2m€153.8m€179.6m€49.1m
Capital spending−€292.4m−€361.9m−€510.0m−€280.6m−€130.6m−€110.8m−€85.3m
Free cash flow€24.7m−€182.1m−€388.6m−€161.4m€23.2m€68.8m−€36.2m
Dividends paid−€16.3m−€16.7m−€16.5m−€15.6m−€12.9m−€10.3m−€7.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue€348.5m€315.7m€396.1m€349.9m€323.2m€296.1m€381.5m€277.9m
Gross profit€100.2m€86.8m€122.2m€102.1m€90.7m€80.7m€113.3m€74.4m
Operating income€45.1m€45.8m€76.1m€60.8m€47.7m€41.3m€77.2m€41.0m
Net income€26.5m€32.3m€54.4m€41.6m€34.3m€30.6m€55.8m€30.0m
Diluted earnings per share0.100.120.200.150.130.110.200.11
Cash from operations€36.0m€87.0m€106.0m€54.0m€51.0m€115.0m€50.0m€129.0m
Capital spending−€75.0m−€81.0m−€101.0m−€55.0m−€69.0m−€82.0m−€102.0m−€256.0m
Free cash flow−€39.0m€6.0m€5.0m−€1.0m−€18.0m€33.0m−€52.0m−€127.0m
Total assets€3.02bn€2.98bn€2.93bn€2.79bn€2.71bn€2.68bn€2.69bn€2.55bn
Cash and short-term investments€96.5m€130.1m€153.2m€130.8m€108.7m€104.7m€113.4m€90.0m
Debt€503.2m€504.7m€530.3m€508.9m€467.3m€441.6m€481.4m€403.4m
Shareholders' equity€1.79bn€1.77bn€1.71bn€1.66bn€1.61bn€1.63bn€1.62bn€1.53bn

Financial ratios

Data as of 23 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin29.0%27.4%31.3%32.5%31.4%29.3%
Operating margin17.9%15.1%17.9%19.5%20.2%15.4%
Net margin11.8%10.7%13.4%14.5%15.9%11.9%
Return on equity9.0%8.4%12.9%14.3%16.0%25.3%
Return on assets5.3%5.1%7.0%8.6%9.5%8.1%
Free cash flow yield9.9%8.8%10.6%6.7%4.8%4.4%
Revenue growth3.2%1.7%10.3%16.6%27.5%23.4%
Earnings growth14.0%-19.1%1.9%6.3%71.1%100.3%
Current ratio1.74x1.84x1.50x1.83x2.56x1.56x
Debt to equity0.31x0.30x0.34x0.20x0.27x1.10x
Equity ratio58.4%60.3%54.7%60.0%59.3%32.1%
Interest coverage9.33x24.35x44.93x48.67x35.01x15.06x
R&D as a share of sales2.1%2.9%3.3%3.5%3.5%2.6%
Buybacks as a share of market value-0.0%-2.8%-0.3%0.0%10.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.9%11.6%—
Operating income-1.6%12.4%—
Net income-2.0%11.3%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin28.2%30.0%30.1%—
Operating margin15.3%17.1%17.3%—
Net margin11.2%12.5%12.9%—

Valuation history

At each fiscal year end

FY2025FY2024
Price to earnings35.437.2
Price to sales4.24.0

Market value over time

30 Jul 2021 to 22 Oct 2026, in EUR

€4.87bn€5.32bn

Share price return

Finished calendar years

20252024
Return-9%-15%

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 11 Jun 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year0.0540.0540.0530.0540.051

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.